Cargando…

DNA Repair and Replication-Related Gene Signature Based on Tumor Mutation Burden Reveals Prognostic and Immunotherapy Response in Gastric Cancer

The genomic variant features (mutations, deletions, structural variants, etc.) within gastric cancer impact its evolution and immunogenicity. The tumor has developed several coping strategies to respond to these changes by DNA repair and replication (DRR). However, the intrinsic relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Hu, Dahai, Huangfu, Shuchen, Zhou, Jiaxin, Wang, Wei, Liu, Shijin, Tang, Hui, Pan, Jinghua, Pan, Yunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766186/ https://www.ncbi.nlm.nih.gov/pubmed/35058980 http://dx.doi.org/10.1155/2022/6469523

Ejemplares similares

Editorial: Novel biomarkers for predicting response to cancer immunotherapy
por: Huangfu, Shuchen, et al.
Publicado: (2023)

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
por: Pham, Timothy V., et al.
Publicado: (2020)

Association of ctDNA detection and recurrence assessment in patients with neoadjuvant treatment
por: Zhou, Jiaxin, et al.
Publicado: (2023)

Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer
por: Chu, Xiao-dong, et al.
Publicado: (2022)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

Case report: The MSI-L/p-MMR metastatic rectal cancer patient who failed systemic therapy responds to anti-PD-1 immunotherapy after stereotactic body radiation-therapy
por: Liu, Shijin, et al.
Publicado: (2022)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
por: Sun, Hengzi, et al.
Publicado: (2019)

Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer
por: Chen, Shimin, et al.
Publicado: (2021)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
por: Pan, Yuting, et al.
Publicado: (2023)

An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2022)

Deficiency of replication-independent DNA mismatch repair drives a 5-methylcytosine deamination mutational signature in cancer
por: Fang, Hu, et al.
Publicado: (2021)

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma
por: Xie, Chan, et al.
Publicado: (2021)

Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer
por: Zhu, Zhenxin, et al.
Publicado: (2020)

DNA REPAIR FOOTPRINT UNCOVERS CONTRIBUTION OF DNA REPAIR MECHANISM TO MUTATIONAL SIGNATURES
por: Wojtowicz, Damian, et al.
Publicado: (2020)

A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer
por: Liu, Shi-jin, et al.
Publicado: (2021)

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
por: Teng, Xu, et al.
Publicado: (2023)

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
por: Gu, Weiguang, et al.
Publicado: (2023)

Construction and Evaluation of a Tumor Mutation Burden-Related Prognostic Signature for Thyroid Carcinoma
por: Lu, Haodong, et al.
Publicado: (2021)

Mutational signatures are jointly shaped by DNA damage and repair
por: Volkova, Nadezda V., et al.
Publicado: (2020)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Prognostic and predictive value of a pathomics signature in gastric cancer
por: Chen, Dexin, et al.
Publicado: (2022)

Mutational signature distribution varies with DNA replication timing and strand asymmetry
por: Tomkova, Marketa, et al.
Publicado: (2018)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers
por: Ying, Jieer, et al.
Publicado: (2021)

Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients
por: Xiang, Li, et al.
Publicado: (2022)

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer
por: Wang, Gaoming, et al.
Publicado: (2022)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review
por: Zhu, Peng-Fei, et al.
Publicado: (2021)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

Correction: Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers
Publicado: (2021)

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
por: Liu, Zijian, et al.
Publicado: (2020)

Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden
por: Raj, Shailaja K. S., et al.
Publicado: (2022)

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023)

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden
por: Ma, Weijun, et al.
Publicado: (2021)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

The use of DNA repair genes as prognostic indicators of gastric cancer
por: Jinjia, Chang, et al.
Publicado: (2019)

Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair
por: Phillips, David H.
Publicado: (2018)

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer
por: Wei, Cheng, et al.
Publicado: (2022)

Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer
por: Zhong, Jinlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fn6sq1cr15e6gt7kuba6s87495